29 April 2015

Molecular Oncology - Past, Present and Future of Anti-Cancer Drug Design

Organised by:

 SCI's London Group in partnership with the New York University in London

NYU in London

Registration Closed

This event is no longer available for registration.


The discovery of effective anti-cancer drugs represents one of the greatest challenges to face humanity. Whilst great progress has been made in both our understanding and our ability to discover new treatments, significant challenges remain.

Dr Michael J Waring will describe the role medicinal chemistry has played in the development of today's established treatments, modern approaches to targeted therapies and future challenges in tackling resistance to these therapies. This will be showcased with stories of how some of today's recognised drugs were discovered and how modern medicinal chemistry approaches have been applied to discover new treatments, which show great promise for the future.

Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

New York University

New York University in London
6 Bedford Square 
London, WC1B 3RA
Please click here for a location map.

SCI Comms Team

Tel: 0207 598 1594

Email: Communications@soci.org


This is a FREE event but booking is required. Places are limited so early registration is advised.

This event is now full, if you would like to be added to the waiting list, please contact communications@soci.org.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd Centre - The CPD Standards Office - CPD Provider 41057 - www.cpdstandards.com


Additional Info


Dr Michael J Waring, Principal Scientist-Medicinal Chemistry, AstraZeneca, UK